NCT03549832View on ClinicalTrials.gov

Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions
HCV Coinfection
Interventions
DRUG

Sofosbuvir

Sofosbuvir 400 mg oral pills

DRUG

Simeprevir

Simeprevir 150 mg oral pills

DRUG

Daclatasvir

Daclatasvir 60 mg oral pills

DRUG

Ribavirin

Ribavirin 200 mg oral pills

DRUG

Ombitasvir/paritaprevir/ritonavir

Ombitasvir/paritaprevir/ritonavir oral pills

Trial Locations (1)

71515

Assiut University Hopsital, Asyut

All Listed Sponsors
collaborator

Sohag University

OTHER

collaborator

South Valley University

OTHER

lead

Assiut University

OTHER

NCT03549832 - Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure | Biotech Hunter | Biotech Hunter